Institut Claudius Regaud
Clinical trials sponsored by Institut Claudius Regaud, explained in plain language.
-
New MRI-Guided radiation aims to extend life in brain cancer patients
Disease control TerminatedThis study tested two types of brain radiation for people with glioblastoma, an aggressive brain cancer. All participants also received chemotherapy. The goal was to see if a newer, MRI-guided radiation method could help patients live longer than standard radiation. The trial was…
Phase: PHASE3 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 16, 2026 23:36 UTC
-
Cancer drug trial for frail seniors halted early
Disease control TerminatedThis study tested the drug pazopanib in frail elderly patients (75 and older) with metastatic cancer that could not be cured. The goal was to find the safest dose and understand side effects. The trial was terminated early after enrolling 18 patients.
Phase: PHASE1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC